Worldwide survey of neonatal screening for biotinidase deficiency.
Neonatal screening for biotinidase deficiency has been conducted in 14 countries since 1984. To 31 December 1990, 8,532,617 newborns were screened. One hundred and forty-two infants with biotinidase deficiency were identified; 76 infants with profound deficiency (less than 10% of mean normal serum activity) and 66 infants with partial deficiency (10-30% of mean normal activity). The estimated incidence of profound biotinidase deficiency is 1:112,271 (1:85,000 to 1:145,000; 95% confidence limits) and the incidence of partial deficiency is 1:129,282 (1:112,700 to 1:177,000). The incidence of combined profound and partial deficiency is 1:60,089 newborns (1:49,500 to 1:73,100). The estimated frequency of the allele for biotinidase deficiency is 0.004 and an estimated 1 in 123 individuals is heterozygous for the disorder.
Wolf
B
B
Department of Human Genetics, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
D000581:Amidohydrolases / Q000172:deficiency*; D043523:Biotinidase; D006306:Health Surveys; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening
D000581:Amidohydrolases; D043523:Biotinidase